BUZZ-Pot stocks fall after DEA hearing on marijuana reclassification begins

Reuters12-02 23:30
BUZZ-Pot stocks fall after DEA hearing on marijuana reclassification begins

** Shares of cannabis firms fall after U.S. Drug Enforcement Administration's $(DEA)$ preliminary hearing on marijuana rescheduling proposal begins

** Tilray Brands TLRY.O falls 1.1% and U.S.-listed shares of Cronos Group CRON.O falls 1.9%

** Toronto-listed shares of Canopy Growth WEED.TO falls 1.3% and Trulieve Cannabis TRUL.CD falls 0.5%

** Last week, DEA said the hearing "will serve as a procedural day to address legal and logistical issues and discuss future dates for the evidentiary hearing on the merits"; the agency said no witness testimony will be heard

** Despite marijuana being legal in dozens of U.S. states, federal law categorizes it as a schedule I drug and prohibits most conventional U.S. banks from doing business with cannabis firms

(Reporting by Pooja Menon in Bengaluru)

((Pooja.Menon@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment